Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

Date and time:
27.09.2021 at 19:00 - 19:30 CEST
Corporate Event
Tina Vilsbøll;
European Association for the Study of Diabetes (EASD)
Industry session on the occasion of the 57th Annual Meeting of the European Association for the Study of Diabetes. At the 57th EASD Annual Meeting, which will be a virtual conference this year, we are happy to feature a series of three live and interactive symposia on Monday 27th September 2021 from 14:30 – 19:30 CEST. The symposia are divided into different therapy areas to help inform delegate attendance based on preference and relevance to their clinical practice. The symposia will be chaired by Professor Tina Vilsbøll who will be joined by a panel of other world-class diabetes and obesity experts who are sure to deliver informative, engaging, and valuable sessions. In this final symposium of the series, which will be a 30-minute short session from 19:00-19:30, we will revisit the highlights and learnings from the earlier symposia.

Watch the video above featuring the symposium Chair, Tina Vilsbøll, for a brief teaser of what you can look forward to at the live meeting.


Highlights and learnings: current diabetes and obesity management and future opportunities

Tina Vilsbøll - Chair

Tina Vilsbøll

Steno Diabetes Center Copenhagen, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark

Professor Vilsbøll has been involved in diabetes research since 1997, and in 2004 she established the Center for Diabetes Research at Gentofte Hospital, University of Copenhagen, Denmark (now part of Steno). Her research is focused on the pathophysiology of obesity, prediabetes, type 2 diabetes, regulation of appetite and food intake, and the utilisation of incretins as therapeutics. Integration of the gut in the understanding of human glucose metabolism has become a major focus in her lab over recent years. 


Professor Vilsbøll is an experienced teacher and supervises several PhD and medical students conducting diabetes research. She has around 350 scientific publications and several published books and book chapters. She is a frequently invited speaker at international meetings. In addition to her teaching and research posts, Professor Vilsbøll is a member of numerous professional societies and committees, and referees for several international journals.

Read full bio